Positron EBITDA 2010-2024 | POSC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Positron ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Positron ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$217.3B
Intuitive Surgical (ISRG)	$204B
Alcon (ALC)	$45.1B
Edwards Lifesciences (EW)	$42B
IQVIA Holdings (IQV)	$35.9B
IDEXX Laboratories (IDXX)	$34.3B
DexCom (DXCM)	$33.8B
Waters (WAT)	$24B
STERIS (STE)	$21.7B
SONOVA HOLDING (SONVY)	$20.8B
Hologic (HOLX)	$16.1B
Fresenius Medical Care AG KGaA (FMS)	$14.6B
Globus Medical (GMED)	$12.6B
Sysmex ADR (SSMXY)	$12.2B
Penumbra (PEN)	$10.4B
Masimo (MASI)	$9.5B
Glaukos (GKOS)	$8.8B
Teleflex (TFX)	$8.4B
Integer Holdings (ITGR)	$4.8B
Inari Medical (NARI)	$4.7B
PROCEPT BioRobotics (PRCT)	$3.8B
Veracyte (VCYT)	$3.4B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.6B
Tandem Diabetes Care (TNDM)	$2.4B
Elekta AB (EKTAY)	$2.3B
TransMedics (TMDX)	$2.2B
Integra LifeSciences Holdings (IART)	$2B
Alphatec Holdings (ATEC)	$1.7B
Artivion (AORT)	$1.3B